RASSF1 and hepatocellular carcinoma: Cell-free methylated RASSF1A exhibited large discrepancies with respect to diagnostic performance, including wide ranges for sensitivity (0.27 to 0.94) and specificity (0.38 to 0.95); this phenomenon was likely due to HCC heterogeneity and the selected methylation assay method [27].